US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist
  • 1.030
  • -0.060-5.50%
Close Nov 21 16:00 ET
  • 1.030
  • 0.0000.00%
Post 20:01 ET
65.25MMarket Cap-1131P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cue Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.268M--
--2024/Q4-- / 1.701M--
--2024/Q33.336M / 1.520M--
--2024/Q22.658M / 1.289M--
--2024/Q11.717M / 1.213M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.268M--
--2024/Q4-- / 1.701M--
--2024/Q33.336M / 1.520M--
--2024/Q22.658M / 1.289M--
--2024/Q11.717M / 1.213M--

Unlock Free Earnings Estimates

Cue Biopharma Earnings Reports

  • Cue Biopharma | 10-Q: Q3 2024 Earnings Report

    Nov 14 16:08 ET

  • Cue Biopharma | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:07 ET

  • Cue Biopharma | 10-Q: Q1 2024 Earnings Report

    May 9 16:05 ET

  • Cue Biopharma | 8-K: Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

    May 9 16:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 20, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data